Infective endocarditis and pseudomonal septic embolizaton in a patient with HIV/AIDS
Endocarditis infecciosa y embolia séptica pulmonar por Pseudomonas aeruginosa en un paciente con VIH/SIDA
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
We describe the case of a 43-year-old male, diagnosed with human immunodeficiency virus infection and acquired immunodeficiency syndrome, not a user of intravenous drugs, who presented with lung cavitation consistent with septic embolization in the context of infective endocarditis of the pulmonary valve and Pseudomonas aeruginosa bacteremia, with a positive clinical and echocardiographic response to antibiotic therapy. Right-sided infective endocarditis is responsible for 5-10% of all cases of endocarditis. Although it can appear in patients with a permanent pacemaker, central venous catheter, or congenital cardiopathy, this situation is more frequently observed in addicts to intravenous drugs. While the tricuspid valve is the most common site of infection, infection of the pulmonary valve and the Eustachian valve can also be observed. In patients with human immunodeficiency virus infection, the incidence of endocarditis has decreased in the era of antiretroviral therapy; it is more common in patients with advanced immunosuppression, and causes more one-year morbidity and mortality, besides a greater risk of arterial embolizaton (pulmonary among others). The incidence of Pseudomonal infective endocarditis has been estimated at about 5% in this group of patients.
Article visits 1797 | PDF visits 1674
Downloads
- Taylor J. The Guidelines for management of infective endocarditis reviewed. Eur Heart J. 2009;30(19):2185-6.
- Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. CardiolClin. 2003;21(2):167-84.
- Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW, O’Gara PT. ACC/AHA 2008 guideline update on valvular heart disease focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Catheter CardiovascInterv. 2008;72(3):E1-12.
- Reyes MP, Ali A, Mendes RE, Biedenbach DJ. Resurgence of pseudomonas endocarditis in Detroit, 2006-2008. Medicine (Baltimore).2009;88(5):294-301.
- Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147(12):829-35.
- Jorens PG, Van Marck E, Snoeckx A, Parizel PM. Nonthrombotic pulmonary embolism.EurRespir J. 2009;34(2):452-74.
- Ordóñez KM, Hernández OA, Cortés JA, López MJ, Alfonso G, Junca A. Endocarditis infecciosa izquierda por Pseudomonas aeruginosa tratada médicamente.Biomédica.2010; 30:164-9.
- Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr. 2006;43(4):426-32.
- Corti ME, Palmieri OJ, Villafañe MF, Trione N. Evaluación de 61 episodios de endocarditis infecciosa adictos a drogas intravenosas e infección por el virus de la inmunodeficiencia tipo-1. Rev Arg Microbiol. 2004;36:85-7.
- Venkatesan A, Spalding C, Speedie A, Sinha G, Rumbaugh JA. Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis. J Infect. 2005;51(4):e199-202.
- Dawson NL, Brumble LM, Pritt BS, Yao JD, Echols JD, Alvarez S. Left-sided Pseudomonas aeruginosa endocarditis in patients without injection drug use. Medicine (Baltimore). 2011;90(4):250-5.
- Navarrete Navarrete N, Tapia Gómez A, López-Gómez M, López-Ruz MA, Jiménez Alonso J. Endocarditis por Pseudomonas aeruginosa. Presentación de un caso atípico y revisión de la literatura. An Med Int (Madrid). 2007;24(2):99-100.
- Hull MW, Phillips P, Montaner JS. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest. 2008;134(6):1287-98.
- Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest. 2008;134(6):1287-98.
- Allen CM, Al-Jahdali HH, Irion KL, Al Ghanem S, Gouda A, Khan AN. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med. 2010;5(4):201-16.
- Dodd JD, Souza CA, Müller NL. High-resolution MDCT of pulmonary septic embolism: evaluation of the feeding vessel sign. AJR Am J Roentgenol. 2006;187(3):623-9.
- Yasar KK, Pehlivanoglu F, Gursoy S, Sengoz G. Tricuspid endocarditis and septic pulmonary embolism in an intravenous drug user with advanced HIV infection. Oman Med J. 2011;26(5):365-7.
- Tembe AG, Kharbanda P, Dalal JJ, Vaishnav G, Joshi VR.Infective endocarditis a tale of two cases and the lessons (re)learned.J Assoc Physicians India. 2010;58:319-22.
- McDonald JR. Acute infective endocarditis. Infect Dis Clin North Am. 2009;23(3):643-64.